AwardTape · Defense awards · Research and development · Health R&D · HT942523C0071
HT942523C0071: $650K definitive contract to Gateway Biotechnology, Inc
Gateway Biotechnology, Inc holds a definitive contract from Defense Health Agency with $650K obligated since Oct 2023 and $1.9M obligated over its life, against a ceiling of $1.9M. Latest action Apr 23, 2026.
Medical research and development contract DHA sbir ph ii, proposal no. h2s-0048, titled: "gw-tt2, a new drug product for tinnitus"
| PIID | HT942523C0071 |
|---|---|
| Type | definitive contract |
| Company | Gateway Biotechnology, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $650K |
| Total obligated (lifetime) | $1.9M |
| Ceiling (base and all options) | $1.9M |
| Base date | Sep 18, 2023 |
| Latest action | Apr 23, 2026 |
| End date | Aug 23, 2027 |
| Actions since Oct 2023 | 3 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | OH |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial